NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹157 Cr | ₹135 Cr | ₹27 Cr | ₹18 Cr | ₹14 Cr |
What is the latest Short Term Provisions ratio of NATCO PHARMA ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹157 Cr |
| Mar2024 | ₹135 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹18 Cr |
| Mar2021 | ₹14 Cr |
How is Short Term Provisions of NATCO PHARMA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹157 Cr | 16.05 | |
| Mar2024 | ₹135 Cr | 400.74 | |
| Mar2023 | ₹27 Cr | 50.84 | |
| Mar2022 | ₹18 Cr | 26.95 | |
| Mar2021 | ₹14 Cr | - | |
Compare Short Term Provisions of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹17,949.4 Cr | 4.8% | 20.8% | 28.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 4.8% |
20.8% |
28.2% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses